Detail Information of Xenobiotics

General Information of Xenobiotics (ID: XEO03804)
Xenobiotics Name
Lantibiotic lichenicidin VK21 A1
Xenobiotics Type
Amino Acid(s), Peptide(s) or Protein(s)
Classification
Peptide
DME(s) Modulated by This Xenobiotics
DME(s) Inhibited by This Xenobiotics
Cytochrome P450 102A1 (cyp102) DME Info Bacillus megaterium [1]
Cytochrome P450 MEG (cyp106) DME Info Bacillus megaterium [1]
Cytochrome P450 21A2 (cyp21) DME Info Bacillus megaterium [1]
Cytochrome P450 BM3 (cypBM3) DME Info Bacillus megaterium [1]
NADPH-dependent oxidoreductase (nfrA) DME Info Staphylococcus aureus [2]
NADPH-dependent nitroreductase (nfrA1) DME Info Bacillus subtilis [3]
Glutamate racemase (MurI) DME Info Bacillus subtilis [3]
Glutamate racemase (MurI) DME Info Bacillus pumilus [2]
General stress protein 14 (ywrO) DME Info Bacillus subtilis [3]
References
1 Isolation, structure elucidation, and synergistic antibacterial activity of a novel two-component lantibiotic lichenicidin from Bacillus licheniformis VK21. Biochemistry. 2010 Aug 3;49(30):6462-72.
2 Identification of a novel two-peptide lantibiotic, lichenicidin, following rational genome mining for LanM proteins. Appl Environ Microbiol. 2009 Sep;75(17):5451-60.
3 Production of the novel two-peptide lantibiotic lichenicidin by Bacillus licheniformis DSM 13. PLoS One. 2009 Aug 26;4(8):e6788.

If you find any error in data or bug in web service, please kindly report it to Dr. Yin and Dr. Li.